Mary Elizabeth Strek to Immunosuppressive Agents
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Immunosuppressive Agents.
Connection Strength
1.286
-
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.
Score: 0.387
-
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther. 2016 Feb; 36:46-52.
Score: 0.365
-
Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. J Rheumatol. 2017 Nov; 44(11):1612-1618.
Score: 0.102
-
Therapeutic Approach to Adult Fibrotic Lung Diseases. Chest. 2016 Dec; 150(6):1371-1386.
Score: 0.095
-
Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016 06; 47(6):1767-75.
Score: 0.093
-
Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
Score: 0.093
-
Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013 Mar; 143(3):814-824.
Score: 0.075
-
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023 11; 62(5).
Score: 0.039
-
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6.
Score: 0.037